Introduction
Methods
Protocol registration and search strategy
Inclusion and exclusion criteria
Data extraction
Quality assessment appraisal
Results
Included studies
Quality appraisal
Study and patient characteristics
Studies | Location or database | Journal | Year of publication | Study design | Measurement method | Time frame of inclusion |
---|---|---|---|---|---|---|
Studies including children only: | ||||||
Avitabile et al. [27] | Children’s Hospital of Philadelphia and Cincinnati Children’s Hospital Medical Center | Journal of American Heart Association | 2022 | Cohort | DXA | January 2019–November 2021 |
Pyykknönen et al. [28] | Helsinki University Hospital | Pediatric Cardiology | 2022 | Prospective interventional study | BIA | – |
Hansson et al. [15] | Northern part of Sweden and Stockholm | Cambridge University Press | 2021 | Cross-sectional | DXA | 2010–2019 |
Sandberg et al. [16] | Northern part of Sweden and Stockholm | Cardiology in the Young | 2020 | Cross-sectional | DXA | September 2017–October 2018 |
Sarafoglou et al. [24] | Children’s Hospital and Clinics of Minnesota and the Masonic Children’s Hospital at the University of Minnesota, Minneapolis, Minnesota, United States of America | Cardiology in the Young | 2020 | Cross-sectional | DXA & CT | – |
Studies including adults only: | ||||||
Chemello et al. [32] | University Hospital of Padua | Journal of Cardiovascular Development and Disease | 2021 | Cohort | BIA | May 2017–May 2020 |
Tran et al. [5] | Adult Congenital Heart Disease Database at Royal Prince Alfred Hospital and Australian and New Zealand Fontan Registry (ANZFR) | Journal of the American Heart Association | 2020 | Cross-sectional | DXA | March 2016–February 2018 |
Ohuchi et al. [17] | – | International Journal of Cardiology | 2019 | Cohort | DXA | September 1990–Septermber 2017 |
Shiina et al.[25] | St. Luke’s International Hospital | Congenital Heart Disease | 2018 | Cohort | BIA | July 2016–December 2016 |
Cordina et al. [18] | Coronary Heart Disease Database at Royal Prince Alfred Hospital (RPAH), Sydney, Australia | Heart–BMJ Journals | 2013 | Cohort | BIA | – |
Studies including children and adults: | ||||||
Tekerlek et al. [30] | – | Elsevier | 2023 | Case–control | BIA | September 2021–January 2022 |
Wadey et al. [31] | Adult Congenital Heart Disease Database at Royal Prince Alfred Hospital and Australian and New Zealand Fontan Registry (ANZFR) | Journal of American Heart Association | 2022 | Cohort | DXA | March 2016–February 2018 |
Cao et al. [19] | Australian and New Zealand Fontan Registry (ANZFR) | International Journal of Cardiology | 2021 | Cohort | DXA | – |
Vaikunth et al. [22] | Children’s Hospital of Philadelphia | The Journal of Pediatrics | 2021 | Cohort | DXA | July 2011–October 2013 |
Possner et al. [26] | Cincinnati Children’s Hospital Medical Center | CJC Open | 2020 | Cross-sectional | DXA | 2000–2018 |
Powell et al. [23] | Cincinnati Children’s Hospital | Journal of the American Heart Association | 2020 | Cohort | Liver or abdominal MRI | April 2019–January 2020 |
Avitabile et al. [20] | Children’s Hospital of Philadelphia | Heart–BMJ Journals | 2018 | Cohort | DXA | July 2011–October 2013 |
Avitabile et al. [21] | Children’s Hospital of Philadelphia | Heart–BMJ Journals | 2014 | Cohort | DXA | July 2011–October 2013 |
Studies | Patient group (n) | Control group (n) | Age (years) | Age at Fontan completion (years) | Female (%) | Fontan type (n) | Dominant left ventricle (%) | Open fenestration (%) |
---|---|---|---|---|---|---|---|---|
Studies including children only: | ||||||||
Avitabile et al. [27] | 20 | – | 15.6 ± 1.7 | – | 50% | ECC 14, LT 6 | 45% | 95% |
Pyykkönen et al. [28] | 16 | – | 14.5 ± 2.6 | 2.9 ± 0.5 | 37.5% | – | 31.3% | 6.3% |
Hansson et al. [15] | 38 | 38 | 12.3 ± 3.9 | 2.4 ± 0.9 | 54% | – | 39% | – |
Sandberg et al. [16] | 43 | 43 | 12.2 ± 3.9 | – | 44% | – | 56% | – |
Sarafoglou et al. [24] | 10 | 11 | 12.2 ± 1.69 | – | 30% | – | 30% | – |
Studies including adults only: | ||||||||
Chemello et al. [32] | 43 | – | 30 ± 9 | – | 39.5% | ECC 20, LT 19, unknown 4 | 74.4% | – |
Tran et al. [5] | 28 | – | 26 ± 7 | – | 54% | APC 3, ECC 14, ICC 11 | 57% | 32% |
Ohuchi et al. [17] | 97 | – | 22.3 ± 5 | – | 36% | APC 7, ECC 47, ICC 43 | 42% | – |
Shiina et al. [25] | 46 (13 Fontan patients) | 12 | 29 ± 5.9 | – | 54% | ECC 11, LT 2 | – | – |
Cordina et al. [18] | 16 | 8 | 30 (SEM 2) | – | 19% | APC 6, TCPC 10 | 50% | – |
Studies including children and adults: | ||||||||
Tekerlek et al. [30] | 21 | 21 | 16.4 ± 6.6 | 9.6 ± 4.69 | 23.8% | – | 66.7% | 47.6% |
Wadey et al. [31] | 89 | – | 23.3 ± 6.7 | – | 52.3% | APC 12, 23 LT, 54 ECC | 61% | – |
Cao et al. [19] | 144 | – | 23 ± 8 (13–45) | 5.1 ± 6 | 46% | APC 19, ECC 87, LT 35, unknown 3 | 59% | 28% |
Vaikunth et al. [22] | 46 | – | 12.5 ± 5.3 (5.1–20) | 2.8 (1.4–15.7) | 50% | ECC 27, LT 19 | 43% | 83% |
Possner et al. [26] | 40 | – | 25.5 ± 7.9 | 4.4 ± 3.8 | 50% | APC 7, ECC 11, LT 2 | 68% | – |
Powell et al. [23] | 47 | 165 | 15 ± 3.1 | 3.9 ± 1.9 | 47% | ECC 31, LT 14, unknown 2 | – | – |
Avitabile et al. [20] | 13 | – | 17.7 (12.7–26) | – | 46% | ECC 5, LT 8 | 54% | 69% |
Avitabile et al. [21] | 50 | – | 11.5 (5.1–33.5) | – | 48% | ECC 29, LT 21 | 32% | 84% |
Measurement methods
Body composition
Studies | BMI patients (kg/m2) | Appendicular lean mass (index) | Leg lean mass (index) | Lean mass (index) | Fat mass (index) | Body fat (%) | Conclusion |
---|---|---|---|---|---|---|---|
Studies including children | |||||||
Avitabile et al. [27]* | Z-score: − 0.08 ± 1.01 | – | Z-score: − 1.38 ± 1.02 | – | – | – | Fontan patients had normal BMI and lower leg lean mass compared to reference values |
Pyykkönen [28] | 21 ± 3 | – | 0.3 ± 0.06 kg/kg | – | – | – | Fontan patients had normal BMI and fat and lean muscle mass in the normal range |
Hansson et al. [15] | 19.3 ± 3.7; Z-score: 0.22 ± 1.2 Controls: 18.5 ± 3.3; Z-score: − 0.13 ± 1.0 | – | 4.01 kg/m2 ± 0.9 kg/m2 Controls: 4.4 kg/m2 ± 1.1 kg/m2 | Total body: 12.90 ± 2.0; kg/m2 Arms: 1.26 ± 0.4; kg/m2 Abdomen: 6.30 ± 1.0 kg/m2 Controls: Total body: 13.28 ± 2.4; kg/m2 Arms: 1.36 ± 0.4; kg/m2 Abdomen: 6.29 ± 1.1 kg/m2 | Total body: 5.75 ± 2.2; kg/m2 Arms & legs: 0.65 ± 0.2 kg/m2 & 2.05 ± 0.6; kg/m2 Abdomen: 2.70 ± 1.4 kg/m2 Controls: Total body: 4.4 ± 1.8; kg/m2 Arms & legs: 0.53 ± 0.2 kg/m2 & 1.85 ± 0.7; kg/m2 Abdomen: 1.68 ± 0.9 kg/m2 | – | Fontan patients had normal BMI, lower lean mass, and higher fat mass compared to controls |
Sandberg et al. [16] | 18.9 ± 3.6 Z-score: 0.1 ± 1.1 | – | 4.0 kg/m2 ± 0.9 Controls: 4.2 kg/m2 ± 1.0 | – | – | – | Fontan patients had normal BMI and lower leg lean mass compared to controls |
Sarafoglou et al. [24]a | 18.4 ± 2.98 Controls: 17.4 ± 1.67 | – | Tibial muscle density: 82.64 mg/cm3 ± 1.59 mg/cm3 Controls: Tibial muscle density: 83.51 ± 1.20 mg/cm3 | – | – | – | Fontan patients had normal BMI and comparable muscle mass in the tibia compared to controls. Indexing was not performed in this study |
Studies including adults: | |||||||
Chemello et al. [32] | Men: 22.2 ± 2.8 Women: 21.8 ± 4.3 | Men: 18.5 ± 5.7 Women: 31.7 ± 8.2 | BMI fell within normal range, no comparison to reference values was made for body composition outcomes | ||||
Tran et al. [5]** | 22.4 (IQR: 20.4–27.3) Z-score: 0.38 ± 1.32 | 18.0 kg ± 4.3; 6.4 ± 1.0 kg/m2 Z-score: − 1.49 ± 1.10 Trunk/appendicular fat ratio: 1.3 (IQR: 1.1–1.8) | – | 15 kg/m2 (IQR: 13.9–16.2) Z-score: − 0.7 ± 1.15 | 6.5 kg/m2 (IQR: 4–9.9) | 30 ± 11 Z-score: 0.23 ± 1.26 | Fontan patients had normal BMI, lower skeletal muscle mass, and increased adiposity compared to reference values |
– | – | – | – | Subgroup ↑ Peak VO2 over time: 20% ± 8 Subgroup ↓ Peak VO2 over time: 27% ± 8 | – | Body fat percentage was lower, and the fat-free percentage was higher in Fontan patients that improved on Peak VO2 over time | |
Shiina et al. [25] | 19.7 ± 4.7 Controls: 21.6 ± 2.1 | – | – | Skeletal muscle: 34.7 ± 4.4 kg/m2 Controls: Skeletal muscle: 43.8 ± 4.4 kg/m2 | 24% ± 9.9 Controls: 20.1% ± 4.0 | – | Fontan patients had normal BMI, lower skeletal muscle mass, and comparable fat percentage compared to controls |
Cordina et al. [18]** | 25.5 (SEM 0.8) Controls: 26 (SEM 3) | – | – | Total body: 16.5 kg/m2 (SEM 0.4) | 7.1 kg/m2 (SEM 0.2) Z-score: − 1.46 (SEM 0.22) | – | Fontan patients had normal BMI, reduced lean mass, and appendicular lean mass compared to controls |
Studies including children and adults: | |||||||
Tekerlek et al. [30] | 18.7 ± 3.9 kg/cm2 Controls: 20.89 kg/cm2 ± 3.7 kg/cm2 | – | 14.4 ± 7.5 Controls: 17.1 ± 7.6 | Fontan patients had lower BMI and comparable fat ratio compared to controls | |||
Wadey et al. [31] | 23.7 ± 5.0 | 17.8 ± 4.5 kg | – | 42.7 ± 9.2 kg | – | – | Fontan patients had decreased lean body mass and increased body fat. Indexing was not performed in this study |
Cao et a. [19]** | 23 ± 4.7 | Z-score: − 1.4 ± 1.1 | – | – | 29% ± 10 Z-score: 0.3 ± 1.1 | Z-score: 0.1 ± 1.3 | Fontan patients had normal BMI; 1/3 had reduced skeletal muscle mass and normal fat mass compared to reference values |
Vaikunth et al. [22]* | Z-score: 0.09 ± 0.97 (R: − 2.49–2.24) | – | Z-score: − 0.9 ± 1.1 (p < 0.001) | – | – | – | Fontan patients had normal BMI and reduced leg lean mass compared to controls |
Possner et al. [26]b | 25.2 ± 4.6 | – | – | Skeletal muscle mass T12: 10.5 ± 2.5 cm2/m2 Skeletal muscle mass L3: 50.7 ± 8.1 cm2/m2 Controls: Skeletal muscle mass1 of males L3: 60.9 ± 7.8 cm2/m2 | – | – | Fontan patients had normal BMI and reduced skeletal muscle mass measured at L3 in male Fontan patients compared with healthy controls |
Powell et al. [23]*** | 22.1 ± 5.7 Z-score: 0.05 ± 1.4 Controls: 21.8 ± 4.1 | – | Right leg: 6.0 ± 2.1; kg Z-score: − 0.5 ± 1.0 Left leg: 6.0 ± 2.1; kg Z-score: − 0.5 ± 1.0 Controls: Right leg: 7.1 ± 2.1; kg Left leg: 7.1 ± 2.1 kg | Right arm: 2.0 ± 0.8; kg Z-score: − 0.4 ± 0.9 Left arm: 2.0 ± 0.8; kg Z-score: − 0.4 ± 1.0 Trunk: 18.3 ± 5.4 kg Z-score: − 0.4 ± 1.0 Controls: Right arm: 2.4 ± 0.9; kg Left arm: 2.3 ± 0.8; kg Trunk: 20.5 ± 5.3 kg | 26.0% ± 11.8 Z-score: 0.4 ± 1.2 Controls: 22.4% ± 9.6 | – | Fontan patients had normal BMI, lower lean body mass, and skeletal muscle mass and higher fat percentage compared to controls |
Avitabile et al. [20]* | – | – | Z-score: − 0.87 ± 0.95 (R: − 2.53–1.11) | – | – | – | Fontan patients had lower leg lean mass compared to controls |
Avitabile et al. [21]* | Z-score: 0.15 ± 0.98 (R: − 2.49–2.24) | – | Z-score: − 0.89 ± 0.91 | Z-score: − 0.33 ± 0.77 | – | Z-score: 0.22 ± 0.99 | Fontan patients had normal BMI and lower leg lean mass compared to reference values |
Studies | Comparison | Measurement outcomes | ||
---|---|---|---|---|
BMI | Fat mass | Muscle mass | ||
Children only | ||||
Avitabile et al. [27] | Reference | Normal | Na | Decreased |
Pyykkönen et al. [28] | No comparison | No comparison | Na | No comparison |
Hansson et al. [15] | Controls | Normal | Higher | Decreased |
Sandberg et al. [16] | Controls | Normal | Na | Comparable |
Sarafoglou et al. [24] | Reference | Normal | Comparable | Comparable |
Adults only | ||||
Chemello et al. [32] | No comparison | No comparison | No comparison | Na |
Tran et al. [5] | Reference | Normal | Higher | Decreased |
Ohuchi et al. [17] | No comparison | Na | No comparison | Na |
Shiina et al. [25] | Controls | Normal | Comparable | Decreased |
Cordina et al. [18] | Controls | Normal | Na | Decreased |
Children and adults | ||||
Tekerlek et al. [30] | Controls | Normal | Na | Comparable |
Wadey et al. [31] | Reference | Normal | Higher | Decreased |
Cao et al. [19] | Reference | Normal | Comparable and higher | Decreased |
Vaikunth et al. [22] | Reference | Normal | Na | Decreased |
Possner et al. [26] | Reference | Normal | Na | Decreased (in males), comparable (in females) |
Powell et al. [23] | Controls | Normal | Higher | Decreased |
Avitabile et al. [20] | Reference | Na | Na | Decreased |
Avitabile et al. [21] | Reference | Normal | Comparable | Decreased |